Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Q2 2026 vs. Q1 2026
How the institutions holding Takeda Pharmaceutical Co Ltd changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 362 | 9 | 379 | +26 |
| Shares | 98.2M | 275.4K | 104.2M | +6.27M (+6.4%) |
| Value | $1.82B | $5.10M | $1.67B | −$142.6M (−7.9%) |
9 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (66)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (40)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q1 2026 and filed for Q2 2026 without it.
Not filed for Q2 2026 yet (9)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Skopos Labs, Inc. | 174,896 | $3.24M |
| First Affirmative Financial Network | 56,101 | $1.04M |
| DGS Capital Management, LLC | 23,106 | $427.9K |
| CWM, LLC | 10,958 | $202.9K |
| U.S. Capital Wealth Advisors, LLC | 10,029 | $185.7K |
| Evelyn Partners Investment Management LLP | 167 | $3.09K |
| Evelyn Partners Investment Management Services Ltd | 98 | $1.81K |
| Sunbelt Securities, Inc. | 35 | $648 |
| Evelyn Partners Asset Management Ltd | 7 | $130 |